NS2 Ophthalmic Drops (0.5%)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Safety and Activity Study of NS2 in Subjects With Allergic ConjunctivitisNCT02578914ALDXPhase 2Completed2015-12Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.